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Abstract
Background: SijunziDecoction (SJZD) is a traditional Chinese medicine prescription used to treat the diseases of
gastrointestinal tract since ancient times. The objective of this study was to investigate the protective effects of
SJZD on TNBS-induced colitis in rats and TNBS-damaged Caco2 cells.
Methods: The rat colitis model was induced by 2, 4, 6-trinitrobenzene sulfonic acid (TNBS). SJZD (2.8 5.6, 11.2 g/kg)
or salazosulfapyridine (SASP) (0.4 g/kg) was administrated orally in rats for 7 days. DAI, pathological scores and the
expression of claudin-2 were evaluated. Then we explored the effect and mechanism of SijunziDecoction Serum
(SJZDS) onTNBS-damaged Caco2 cells to figure out intestinal barrier protective effect and mechanism of SJZD.
Results: SJZD significantly ameliorated the severity of TNBS-induced colitis and downregulated the level of claudin-2
in colonic tissues. SJZDS promoted proliferation and inhibited apoptosis ofTNBS-damaged Caco2 cells. In Caco2 cell
monolayers, we provided mechanistic evidence that SJZDS-induced increased TEER and decreased permeability after
TNBS damage, which were mediated through claudin-2 and NF-κB pathway, including the upregulation of claudin-2,
decreased activity of NF-κB p65, reduced level of NF-κB p65 and MLCK.
Conclusions: Our results indicated that SJZD possesses protective effect of intestinal barrier towards TNBS-induced
colitis in rats and TNBS-damaged Caco2 cells in vitro. SJZDis a potential protective agent of intestinal barrier that
deserves further investigation.
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Background
Inflammatory bowel diseases (IBDs) are chronic recur-
rent inflammatory diseases of the gastrointestinal tract,
mainly including Crohn’s disease (CD) and ulcerative
colitis (UC) [1, 2]. The development of IBDs is linked to
characteristic changes in the colon, such as epithelial cell
necrosis and ulceration, local infiltration by immune
cells, including a significant number of neutrophils and
T cells [3]. The ongoing activation of the mucosal im-
mune system are considered to be the major patho-
logical agents of IBDs [4].
The epithelium of the mucosa plays an essential role
in maintaining balance of intestinal ecosystem [5]. The
tight junction complexes play a decisive role in the
maintenance of barrier integrity [6]. Tightjunctions are
multi-protein complexes, which composed of transmem-
brane proteins, peripheral membrane (scaffolding) pro-
teins and regulatory molecules. The claudin protein
family is the most important transmembrane proteins,
which can impact the tight junction permeability. The
transmembrane proteins also include occludin, which
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interacts directly with claudins and actin. Zonula oc-
cludens 1 (ZO1) and ZO2 are peripheral membrane pro-
teins which play a crucial role on tight junction assembly
and maintenance [7].
Currently, conventional drugs used for treatment of IBD
are including immunosuppressants, corticosteroids, disease
improving agents and biological agents, such as TNF anti-
bodies. However, most of these medicines only temporarily
alleviate the symptoms, and are associated with mild to
serious side effects, leading to their limited clinical applica-
tions [8]. Thus traditional Chinese Medicine Formulas
gaining more and more attention in the treatment of IBD,
due to its effective and safe [9]. Some clinical and experi-
mental studies have shown that Chinese formulas for treat-
ment of IBD were effective, and most of their mechanisms
were related with anti-inflammatory, anti-oxidant and re-
store the function of intestinal barrier [10–12].
Sijunzi Decoction (SJZD),also known as Four Gentleman
Decoction, is a classical prescription for curing spleen
deficiency in traditional Chinese medicine, consisting
of Ginseng Radix et Rhizoma, or Codonopsispilosula,
Atractylodes Macrocephalae Rhizoma, Poria, and Gly-
cyrrhizae Radix et Rhizoma Praeparatecum Melle.
Modern pharmacological experiments have proved that
saponin, flavonoid, and polysaccharide are the most active
ingredients in SJZD [13]. SJZD has been used for years in
China to regulate the gastrointestinal function and en-
hance the immunity [14]. However, molecular mecha-
nisms by which SJZD suppressed inflammation bowel
disease were unclear. In the present study, we aimed to in-
vestigate the therapeutic efficacy of SJZD against IBD.
Also, we analyzed the expression of tight junction related
protein to investigate the mucosal barrier protective
mechanism of SJZD in vitro.
Methods
Reagents and chemicals
DMEM medium, fetal bovine serum (FBS) and NEAA
were purchased from GIBCOLaboratories (Grand Island,
NY, USA). 2, 4, 6-trinitrobenzene sulfonic acid (TNBS),
MTT were purchased from Sigma-Aldrich (St. Louis,
Mo, USA). Salazosulfapyridine (SASP) was purchased
from Tongda Pharmaceutical Company Ltd. (Datong,
Shanxi, China). The anti-claudin 2 antibody, anti-myosin
light chain kinase antibody and NF-κB p50/p65 tran-
scription factor assay kit were all obtained from Abcam
(Cambridge, MA, USA). Trizol and cDNA synthesis kit
were obtained from Invitrogen (Carlsbad, CA, USA).
The RT-PCR primers were synthesized by Invitrogen
(Shanghai, China).
Plant materials
Sijunzi Decoction (SJZD) was composed of Ginseng Radix
et Rhizoma, Atractylodes Macrocephalae Rhizoma, Poria,
and Glycyrrhizae Radix et Rhizoma Praeparate cum
Melle, and these four drugs were in same ratio as
described in Pharmacopoeia. Dried herbs were pur-
chased from Kangmei Pharmaceutical Company Ltd.
(Guangzhou, Guangdong, China).
Preparation of Sijunzi Decoction (SJZD)
The preparation of concentrated water decoction of SJZD
was as follows: The herbs (composed of Ginseng Radix et
Rhizoma, Atractylodes Macrocephalae Rhizoma, Poria,
and Glycyrrhizae Radix et Rhizoma Praeparate cum
Melle, the ratio of four herbs was 3: 3: 3: 2 and the total
quantity was 216 g) were placed in a container, and soaked
in cold water of about 7 times the amount of herbs for
2 h; the herbs were boiled for 30 min and then filtered.
Next, the herbal drugs were added with water of about 5
times the amount of the drugs, then decocted and boiled
for 30 min and filtered again. At last, the two filtrates were
mixed together. Three drug concentrations (1.12 0.56 and
0.28 g/ml) were prepared and stored at 4 °C.
Preparation of Sijunzi Decoction-serum (SJZDS)
Twenty male SD rats (6–8 weeks old, 180–200 g) were
purchased from the Experimental Animal Center of
Guangdong Provincial Hospital of Chinese Medicine.
Rats were divided randomly into two groups and were
given SJZD or equivalent volume of saline. Rats were ad-
ministered orally with SJZD at 0.5 g/kg twice a day for
4 days. Then, 1.5 h after the last administration, blood of
the rats was collected from the abdominal aorta under
ether anesthesia. Blood from the same group was mixed
and centrifuged to obtain serum. The serum was heat-
inactived at 56 °C and sterilized by membrane filtration
before use. The serum of rats administered with vehicle
alone was also prepared as control.
Animals
Female Wistar rats (6–8 weeks old, 180–200 g) were
obtained from the Experimental Animal Center of
Guangdong Province (Guangzhou, China). All rats were
fed on a standard diet, had free access to water and were
housed under standard laboratory conditions. All experi-
ments were approved by the Animal Welfare and Ethics
Branch of the Biomedical Ethics Committee of
Guangzhou University of Chinese Medicine.
Induction of colitis
Colitis was induced using the TNBS, as described previ-
ously. The rats that had been fasted for 24 h with free
access to water were anesthetized with 10% chloral hy-
drate, and a polyethylene catheter (2 mm in outer diam-
eter) was inserted rectally (6–8 cm from the anus).
Then, 100 mg/kg TNBS dissolved in 0.25 ml of 50%
ethanol was administered through the catheter. After
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administration of TNBS, rats were held in headfirst
position for 3 min to prevent the solution leaking
out. Then, the animals were placed in separate cages
with free access to food and water. Control rats re-
ceived 0.9% saline. Stool consistency and occult blood
were recorded daily. Rats were sacrificed after 7 days
treatment. The colonic tissues were quickly removed
and rinsed with ice-cold PBS.
SJZD administration
After a 1-week adaptive period, rats were randomly divi-
dedinto four groups (n = 8) as follows. (1) The control
group and TNBS group received 2 ml saline via the rec-
tum; (2) The TNBS + low dose of SJZD group received
SJZD at concentration of 2.8 g/kg;(3) The TNBS +
medium dose of SJZD group received SJZD at concen-
tration of 5.6 g/kg; (4) The TNBS + high dose of SJZD
group received SJZD at concentration of 11.2 g/kg;(5)
The TNBS + SASP group received SASP at concentra-
tion of 0.4 g/kg; Drug administration to animals began
24 h after induction of colitis and was treated for 7 days.
Histological assessment of colitis
Formalin-fixed colon sections were embedded in paraffin
and sectioned (7 μm), then stained by hematoxylin and
eosin (H&E). Histopathologic severity was scored using
three different parameters as previously described: severity
of inflammation (0, none; 1, mild; 2, moderate; 3, severe);
extent of inflammation (0, none; 1, mucosa; 2, mucosa
and submucosa; 3, transmural);crypt damage (0, none; 1,
basal one-third damaged; 2, basal two-thirds damaged; 3,
crypt lost but surface epithelium present; 4, crypt and sur-
face epithelium lost). All parameters were scored by two
independent observers in a blinded manner.
Immunochemistry
The sections were dewaxed by heating at 55 °C for
30 min, washed twice for 15 min, rehydrated in ethanol
for 15 min, proceeded in water bath at 95 °C for 5 min
for antigen unmasking, and treated with 3% hydrogen
peroxide for 30 min. The sections were then incubated
at 4 °C overnight with anti- claudin-2 antibody diluted
1:500. Next, the sections were washed with PBS and in-
cubated secondary antibody at 37 °C for 30 min. 3’3-di-
aminobenzidine tetrachloride was added to observe the
positive expression. Negative control sections were incu-
bated with PBS instead of primary antibody. The expression
of claudin-2 was quantified by image-pro plus software.
Cell culture
The human colon adenocarcinoma cell line Caco2, pur-
chased from the Cell Culture Unit of Shanghai Scicence
Academy (Shanghai, China), Cells were grown in
DMEM supplemented with 10% FBS and 1% NEAA in a
humidified 5% CO2 atmosphere at 37°C.
TNBS damage model of cells
For TNBS damage model of cells, the Caco2 cells were
treated with 200 μg/ml TNBS for 24 h. The Caco2 cells
incubated with DMEM media were used as control.
Cell viability assay
Cell viability was determined by the MTT assay. Cells
were plated at a density of 5000 per well in 96-well plates
in DMEM+ 10% FBS + 1% NEAA and then treated with
200 μg/ml TNBS. After exposure to TNBS for 24 h, SJZDS
or control serum (cs) was added for 24 h, then10 μl MTT
solution was added for 4 h. The cells were lysed with
0.04 N HCL in isopropyl alcohol, and the absorbance was
read at 570 nm. Cell viability was calculated as follows: cell
viability (%) = absorbance of test group/absorbance of con-
trolled cell group × 100%.
Hoechst 33342 staining
For analysis of chromatin condensation or nuclear frag-
mentation, SJZDS-treated cells after TNBS damage were
harvested and fixed in 3% paraformaldehyde (PFA) for
20 min, incubated in 0.1% Triton-X100-PBS for 30 min,
then stained in 0.25 μg/ml Hoechst 33342 for 15 min.
The cells were observed using the IX70 fluorescence
microscope (Olympus, Japan).
Electrical resistance measurements
Transepithelial electrical resistance (TEER) of Caco2 cells
was monitored using an EVOM TEER meter (Millipore).
TEER increased until day 7 when a steady state of higher
than 200 Ω cm2 was reached, indicating the formation of
complete tight junction, an intact monolayer and maxi-
mized integrity of barrier function [15]. TNBS stimulation
of Caco2 cells lasted for 24 h until addition of SJZDS.
After removal of TNBS, the Caco2 cell monolayers was
washed with PBS, numerical readings of TEER were re-
corded at 24 h after the co-incubation of Caco2 cells and
SJZDS.
Permeability study
All transport studies were conducted at 37 °C, in a
medium of DMEM+ 10% FBS + 1%NEAA. Prior to the
transport study, cell monolayers were washed with PBS,
phenolsulfonphthalein at final concentrations of 20 mg/L
in distilled water was added to the apical compartment.
The basolateral compartment contained only water. After
4 h, 150 μl of samples were removed from the basolateral
compartment into 2 ml EP tubes which possess 1.5 ml
NaOH (20 μmol/ml) for neutralization. The absorbance at
570 nm was measured.
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Real time-PCR analysis
The SJZDS-treated Caco2 cells were harvested at 24 h
after the addition of TNBS or vehicle to analyze the ex-
pression of ZO-1, ZO-2, ZO-3, claudin-1, claudin-2,
claudin-3, claudin-4, occludin, JAM, E-cadherin and
GAPDH mRNAs. Total RNA was isolated using Trizol re-
agent. RNA purity and concentration were assayed with a
NanoDrop 2000 devise (Thermo Scientific, Wilmington,
DE, U.S.A.). The mRNAs were then reverse transcribed
directly into cDNA using a RT-PCR kit according to the
manufacturer’s instructions. PCR amplification conditions
were as follows: initial denaturation at 95 °C for 15 s
followed by 35 cycles of denaturation at 95 °C for 5 s and
annealing at 61 °C for 15 s. The sequences of the respect-
ive sense and antisense primers were as follows (from
5’to 3’): CAACATACAGTGACGCTTCACA and CAC
TATTGACGTTTCCCCACTC for ZO-1; ATGGAAGA
GCTGATATGGGAACA and TGCTGAACTGCAAAC
GAATGAA for ZO-2; GCTTTGGCATTGCGATC
TCTG and GATGTGGTCGCCTGTCTGTAG for ZO-3;
AGGAATTAACTGCATACGTTTTGG and TAGCCAC
AGAAAGCATCGGG for claudin-1; GCCTCTGGATGG
AATGTGCC and GCTACCGCCACTCTGTCTTTG for
claudin-2; AACACCATTATCCGGGACTTCT and GCG
GAGTAGACGACCTTGG for claudin-3; TGGGGCTAC
AGGTAATGGG and GGTCTGCGAGGTGACAATGTT
for claudin-4; ACAAGCGGTTTTATCCAGAGTC and
GTCATCCACAGGCGAAGTTAAT for occludin; TGT
TTCAGTTCTGTGTCATGGT and TGCAGACAAGG
TGTTTTCCAG for JAM; CGAGAGCTACACGTTCA
CGG and GGGTGTCGAGGGAAAAATAGG for E-
cadherin; GGAGCGAGATCCCTCCAAAAT and GGC
TGTTGTCATACTTCTCATGG for GAPDH. Relative
mRNA quantities were determined by using the
2ΔΔCt method with data normalized to the GAPDH
housekeeping gene.
Immunofluorescence
Caco2 cells were seeded in the wells of 6-well plates and
cultured overnight. TNBS damaged cells were treated
with SJZDS (15%) for 0, 24, 36, 48 h. After the treatment
of SJZDS, Caco2 cells were fixed in 3% paraformalde-
hyde (PFA) for 30 min, incubated overnight at 4 °C with
anti-claudin 2 antibody, followed by incubation for 1 h
with anti-rabbit IgG-FITC at 1:200 dilution. Finally, an
immunofluorescence assay was carried out according to
the protocol by a fluorescence microscope (Olympus,
BX51, Japan).
Measurement of NF-κB p65 activity
The cellular extracts were prepared, the activity of NF-
κB p65 transcription factor was measured using NF-κB
p50/p65 transcription factor assay kitaccording to the
manufacturer’s instructions.
Western blot analysis
The cells were plated in 6-well plates at density of 1 × 106
per well, TNBS damaged cells were treated with SJZDS
(15%) for different times. After the indicated times, cells
were collected and lysed in lysis buffer [50 mM Tris
(pH 7.4), 150 mM NaCL, 1% Triton X-100, 1% sodium
deoxycholate, 0.1% sodium dodecylsulfate (SDS), 1 mmol/
l phenylmethylsulphonyl fluoride, and protease inhibitors].
The protein concentration was measured by BCA assay
kit, equal amounts of protein were separated by 12.5%
SDS-PAGE, then transferred to nitrocellulose membranes.
The membranes were blocked and incubated overnight at
4 °C with primary antibodies, followed by incubation for
1 h with the secondary antibodies. Finally, protein ex-
pression was detected using the Bio-rad Imaging System
(Bio-rad Biosciences, USA).
Statistical analysis
Results were expressed as the mean ± SEM. Statistical
analysis was carried out by the Student’s t-test, P values
less than 0.05 were considered significant. At least three
independent experiments were performed.
Results
SJZD ameliorated clinical parameters in rats with TNBS-
induced colitis
To determine whether oral administration of SJZD could
ameliorate the intestinal damage in colitis rats, we induced
colitis by administration of TNBS and then treated the
rats with SJZD or SASP (positive control) for 7 days. From
Fig. 1a, the TNBS group had a sharp increase of the DAI
(3.83) from start to day 5, and symptoms were maintained
during the experimental period. Compared to the TNBS
group, medium and high dose of SJZD significantly de-
creased the disease severity of TNBS-induced colitis.
SASP also reduced the DAImarkedly compared with the
TNBS group.
SJZD decreased histological changes in rats with TNBS-
induced colitis
From Fig. 1b and c,histological analysis of the rat colonic
tissues revealed a significant reduction in colon inflamma-
tion and epithelial cells disruption after the administration
of SIZD, compared to the TNBS group. Numerous neu-
trophils and granulocytes, erosion of mucosal layers were
present in the colon of the TNBS group, and a signifi-
cantly reduced influx of inflammatory cells and intact
architecture of the crypts were observed in the colon of
the SJZD and SASP treated rats.
SJZD upregulated the level of claudin-2 in colon of TNBS-
induced colitis rats
Since claudins are the most important transmembrane
proteins which can impact the permeability of tight
Lu et al. BMC Complementary and Alternative Medicine  (2017) 17:35 Page 4 of 13
junction, we investigated the expression of claudin-2 in
colon tissue by immunochemistry. From Fig. 2, com-
pared to control group, the expression of claudin-2 was
downregulated in TNBS-induced colitis rats. The level
of claudin-2 was upregulated after the treatment of SJZD
and SASP, compared to the TNBS group.
SJZDS promotes the growth of TNBS-damagedCaco2 cells
The protective effect of SJZDS on TNBS-damagedCaco2
cells was initially determined by the MTT viability assay.
From Fig. 3a, it was noted that SJZDSpromoted the pro-
liferation of TNBS-damagedCaco2 cells significantly in a
dose-dependent manner, when the concentration of
SJZDS achieved15 and 20%, the growth promotion was
moresignificant.
SJZDS inhibited cell apoptosis of TNBS-damaged Caco2 cells
To determine whether the growth protection of SJZDS on
TNBS-damaged Caco2 cells was related to the inhibition
of cell apoptosis, several apoptotic parameters were mea-
sured. Fluorescence microscopic examination indicated
that Caco2 cells displayed markednucleus condensation
after TNBS treatment, as shown in Fig. 3b. After treat-
ment of 15% SJZDSfor 24 h, the amount of shriveled nu-
cleus decreased. After treatment of TNBS-induced Caco2
cells with 15% SJZDSfor 24 h, the percentage of cell apop-
tosis decreased from 69.6 ± 1.6% to 44.2 ± 3.8% (Fig. 3c, d).
SJZDS enhanced the TEER of Caco-2 cells and reduced the
permeability
To investigate whether SJZDS can protect the barrier
function of Caco2 cells monolayer, we analyzed the
Fig. 1 SJZD has a protective effect against TNBS-induced colitis. a The disease activity index (DAI) were monitored. b Representative histological
photograph of colon sections. c Microscopic score of sections (*P < 0.05, **P < 0.01 and ***P < 0.001 vs. control group; #P < 0.05, ##P < 0.01 and
###P < 0.001 vs. TNBS-induced colitis group; n = 8)
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TEER and permeability of Caco2 cells following SJZDS
treatment. From Fig. 4a, SJZDSenhanced the TEER of
Caco2 cells monolayer at 24 h, as measured by EVOM
TEER meter. Besides, SJZDS can reduced the permeabi-
lityof Caco2 cells (Fig. 4b).
SJZDS protectedbarrier function of Caco2 cells monolayer
via regulating claudin-2
There is increasing evidence that the change of tight
junction can influence the intestinal barrier function,
which is usually related to an increased permeability and
a decrease in TEER [16]. To investigate the underlying
protective mechanism of barrier function in Caco2 cells,
we analyzed the tight junction protein following SJZDS
treatment. From Fig. 5, TNBS can induce the downregu-
lation of different tight junction proteins, and SJZDS
promotes the expression of claudin-2, as measured by
RT-PCR, but SJZDS has no significant effect on the ex-
pression of other tight junction proteins.
Furthermore, we quantify the protein expression of
claudin-2 by western blot and immunofluorescence. As
shown in Fig. 6, the level of claudin-2 was decreased sig-
nificantly after TNBS damage at 24 h, SJZDS treatment
upregulates the expression of claudin-2 for 24 and 36 h,
correspondingly, the results of immunofluorescence
were similar (Fig. 7).
These results suggested that the protein of claudin-2
might be involved in the protective mechanism of bar-
rier function induced by SJZDS.
SJZDS upregulated the level of claudin-2 to protect
barrier function via inhibiting NF-κB signaling activation
Research reveals that claudin-2 has an important role in
inflammation of colon,there is a relationship between
claudin-2 and MLCK, which followed the activation of
Fig. 2 Effect of SJZD on tight junction protein claudin 2 of TNBS-induced colitis in rats by immunochemistry. a Representative immunochemical
photograph of colon sections, the original magnification was 400×. b Quantification of integrated optical density (IOD) in claudin-2. Data represented
the mean ± SEM of at least three independent experiments (*P < 0.05 vs. control group; #P < 0.05, ##P < 0.01 and ###P < 0.001 vs. TNBS-induced colitis
group; n = 8)
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NF-κBpathway [17]. To investigate whether SJZDS has
effect on NF-κB signaling in TNBS-damaged Caco2
cells, we measured the activity of NF-κB p65transcrip-
tion factor and protein expression level of NF-κB p65
and MLCK.
The cellular subfractions were prepared after 15%
SJZDS treatment for 3, 6 and 9 h. As shown in Fig. 8a,
compared to control group, the activity of NF-κB p65
was increased significantly after TNBS damage for 24 h,
after SJZDS treatment for 3 and 6 h, the activity of NF-
κB p65 was markedly decreased.
As shown in Fig. 8b and c, the western blot analysis
revealed that SJZDS decreased the level of NF-κB p65
protein in TNBS-damaged Caco2 cells after treatment
for 6 and 9 h. Moreover, as shown in Fig. 8d and e, treat-
ment with SJZDS resulted downregulation in the level of
MLCK at different times.
Discussion
As an important physical barrier, the intestinal epithe-
lium acts as a guard to protect intestinal tract against
bacteria, pathogens and other antigens invaded into the
intestinal mucosa and contacted with immune system to
prime the abnormal immune responses [18]. The integ-
rity of intestinal barrier can stabilize the entire intestinal
ecosystem. And tight junction (TJ) complexes have a de-
cisive effect on the maintenance of barrier integrity [6].
The tight junction (TJ) is a multiprotein complex has
roles in selectively regulating paracellular transport of
ions and small molecules, preventing endotoxins and
microorganisms passing through. Tight junction pro-
teins include transmembrane proteins (such as occludin
and claudins), peripheral membraneproteins (such as
ZO-1, ZO-2, ZO-3) and regulatory molecules. [19–21].
Defective TJs of the intestinal epithelium have been
shown to be an important pathogenic factor of inflam-
matory bowel diseases [22–25]. Restore the TJ function
would be possible as a new target for treatment of IBD.
SijunziDecoction (SJZD) is one of the most famous
Traditional Chinese herbal formula and had been used
in clinical for treatment of gastrointestinal disorders over
2000 years. It could effectively attenuate nausea,vomitin-
gand diarrhea to restore the homeostasis of the digestive
tract in patients [26]. Ten active components in SJZD
had been verified, including ginsenoside Rg1, Re, Rb 1,
liquiritin, liquiritigenin, glycyrrhizic acid, atractylenolide
Fig. 3 SJZD Serum promoted proliferation and inhibited cell death of TNBS-damaged Caco2 cells. a Caco-2 cells were treated with various
concentrations of 5–20% Control Serum (CS) or SJZD Serum (SJZDS) for 24 h, the effect of SJZDS on cell viability was measured using the MTT assay. b
TNBS-damaged Caco2 cells were incubated in the medium with 15% CS or 15% SJZDS for 24 h, then stained with Hoechst 33342 and observed using
a fluorescence microscope. Apoptotic cells wereindicated by the arrows (×200magnification). c TNBS-damaged Caco2 cells were treated with 15% CS
or 15% SJZDS for 24 h. The induction of apoptosis was determined byAnnexin V-FITC/PI staining assay. d Quantification of the number of apoptotic
cells. Data represented the mean ± SEM of at least three independent experiments (***P < 0.001 vs. control Caco2 cells group; ##P < 0.01
vs. TNBS-damaged Caco2 cells group)
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I, atractylenolide II, atractylenolide III and pachymic
acid [14]. Many of these active ingredients had been
reported could reduce the symptoms of IBD. For ex-
ample, GinsenosideRg1, could restrict inflammation
progress via improving hypercoagulability and micro-
circulation, including the prolonged prothrombin time
(PT), activated partial thrombin time (APTT) and
thrombin time (TT), downregulation of thromboxane
B2 (TXB2) to alleviate the symptoms of UC [27]. The
butenolidederivatives from Atractylodesmacrocephala
showed potent inhibitory effects on NO production in
lipopolysaccharide-induced RAW 264.7 cells and ex-
hibited moderate cytotoxicity against HL-60 cell line
[28]. Our research group has found Carboxytmethyl-
pachymaran (CMP), extracted from Poriacocos could
ameliorate TNF-α-induced damage of intestinal epi-
thelial barrier in Caco-2 monolayers by suppression
MLCK-MLC phosphorylationsignaling pathway [29].
However, the research on pharmacological effects and
mechanisms of SJZD for treatment IBD is still
limited.
Thus, in the present experiments, we explored the ef-
fects of SJZD on TNBS-induced colitis rat model, then
we investigated TEER, permeability, expression of TJs
and NF-κB signaling way of TNBS-damaged Caco2 cells
monolayer, further to figure out intestinal barrier pro-
tective effect and mechanism of SJZD.
TNBS has long been used as an effective inducer to
make mimic experimentally colitis model to investigate
the pathophysiological mechanism of inflammatory
bowel diseases and to determine the mechanism and ef-
ficacy of drugs. TNBS-ethanol administration could in-
duce the inflammation and structure disrupt of mucosa,
submucosa and transmural in colon, characterized by
Th1-driven inflammation [30], and has been regarded as
a similarmodel for CD [31, 32].
In this study, we provided the first evidence that SJZD
plays an important role in the protection of TNBS-
induced colitis. Our results showed that DAI scores and
microscopic scores of colon pathology were significantly
reduced in TNBS-induced colitis by SJZD. Moreover,
the most important finding was that SJZD could upregu-
late the level of claudin 2 by immunochemistry in
TNBS-induced colitis. These findings suggest that SJZD
effectively reduces inflammation and tissue damage of
colon in rats.
In the 1980s, Japanese scholars first proposed the
serum contained Chinese medicine as an important
method of pharmacological study. There are many
componentsin Chinese medicine, which may be chan-
ged in the period of absorption and metabolism in
vivo [33, 34]. The componentsafter absorption and
metabolism, would be transported to the target organ
or tissue to make effect [35]. Therefore, we can use
Fig. 4 Effect of SJZDS on barrier function of Caco2 cells monolayers. a SJZDS significantly increased the TEER of Caco2 cells monolayers. b SJZDS
markedly attenuated the phenolsulfonphthalein flux across the epithelia monolayers. Data represented the mean ± SEM of at least three independent
experiments (*P < 0.05, **P < 0.01 vs. control Caco2 cells group; #P < 0.05, ##P < 0.01 vs. TNBS-damaged Caco2 cells group)
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serum of SJZD (SJZDS) to further explore the effect
and mechanism of SJZD in vitro.
Human Caco2 intestinal epithelial cells are polarized
epithelial cells which could form apical junction com-
plexes, resulting in high electrical resistance, are useful
for studying effects of therapies on permeability.
Then, we investigated the effect and mechanism of
SJZDS on intestinal barrier protection in TNBS damaged
Caco2 cells. Our results showed TNBS could inhibit
proliferation and induce apoptosis of Caco2 cells, lead
morphological changes by Hoechst 33342. SJZDS was
able to antagonize this effect, which could promote pro-
liferation and reduce apoptosis of cells.
Restoring physical barrier function is crucial in the
treatment of intestinal inflammatory disorders. After
24 h TNBS damage on Caco2 cell monolayers, TEER de-
creased from 355.2 ± 6.9 to 324 ± 1.8Ω cm2, then in
SJZDS-treated Caco2 cells, TEER increased from 324 ±
1.8 to 341 ± 0.88Ω cm2. TNBS induced drop in Caco2
TEER correlated directly with the increase in paracellu-
lar permeability. SJZDS could decrease paracellular per-
meability of Caco2 cell monolayers for 24 h.
To explain the relationship between the TJ proteins and
barrier function, we analyzed a series of TJ proteins by
RT-PCR, the results showed TNBS could downregulate
the mRNA level of ZO-1, claudin-1, claudin-2 in Caco2
cells, after SJZDS treatment, the mRNA level of claudin-2
was upregulated. So we next focused the target of SJZDS
on claudin-2, the treatment of TNBS-damaged Caco2 cells
with SJZDS resulted in the increase in the expression of
claudin-2 by western blot and immunofluorence.
NF- κB, an important nuclear transcriptional factor, its
signaling pathway has been involved in numerous
physiological processes, including regulation of
Fig. 5 Expression of tight junction proteins in Caco2 cells monolayers. Total RNA was isolated from Caco2 cells, RT-PCR was used to investigated
the level of various tight junction proteins. Data represented the mean ± SEM of at least three independent experiments (*P < 0.05 vs. control
Caco2 cells group; ##P < 0.01 vs. TNBS-damaged Caco2 cells group)
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Fig. 6 SJZDS modified the expression of claudin 2. a The figure showed a representative western blot of claudin 2 in TNBS-damaged Caco2 cells
treated by SJZDS for 24 h. b Quantification of the amounts of claudin 2relative to GAPDH for 24 h. c The figure showed a representative western
blot of claudin 2 in TNBS-damaged Caco2 cells treated by SJZDS for 36 h. d Quantification of the amounts of claudin 2relative to GAPDH for 36 h. e
The figure showed a representative western blot of claudin 2 in TNBS-damaged Caco2 cells treated by SJZDS for 48 h. f Quantification of the amounts
of claudin 2relative to GAPDH for 48 h. Data represented the mean ± SEM of at least three independent experiments (*P < 0.05, **P < 0.01 vs. control
Caco2 cells group; ##P < 0.01 vs. TNBS-damaged Caco2 cells group)
Fig. 7 Effect of SJZDS on tight junction protein claudin 2 of TNBS-damaged Caco2 cells by Immunofluorescence. Results were reported from
three independent experiments, original magnification was 400×
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inflammation response and innate immunity, and there-
fore may be participation in IBD in multiple ways [36].
The increased expression of NF-κB in the acute phase of
colitis had been proved and is consistent with its role in
the onset of experimental colitis [37]. SJZDS could sig-
nificantly inhibit NF- κB p65 activity and expression in
nuclear after treatment for 3 h and 6 h, make it impos-
sible to block downstream cytokine and inflammatory
factors expression.
TJs are closely link to various intracellular signaling
molecules and are regulated by multiple signal trans-
duction pathways. Myosin light chain kinase (MLCK)
is classically known to be required for the contraction
of actomyosin via the phosphorylation of myosin light
chain (MLC) [38] and has also been reported to be
expressed in the human intestinal tissue with IBD
[39]. It is also essential to regulation the permeability
of epithelial barrier and affects production of inflam-
matory cytokine, such as TNFα, in the inflamed intes-
tinal tissues. Inhibition of MLCK can attenuate TNFα
induced nuclear translocation of p65 and phosphoryl-
ation of IκB, which indicates MLCK play a role in in-
ducing activation of NF-κB [40]. We next investigated
the level of MLCK. The results showed that the ex-
pression of MLCK was increased in TNBS-damaged
Caco2 cells, SJZDS decreased the level of MLCK at
different times.
Conclusions
In this study, our results demonstrate that SJZD ame-
liorates the severity of TNBS-induced colitis and
downregulates the level of claudin-2 in colonic tis-
sues. In vitro data showsSJZDS promotes proliferation
and inhibits apoptosis ofTNBS-damaged Caco2 cells.
In Caco2 cell monolayers, SJZDS increases theTEER
andreduces permeability after TNBS damage, we finds
that the barrier protective effect of SJZDS is mediated
through claudin-2 and NF-κB pathway, including up-
regulation of claudin-2, decreased activity of NF-κB
p65, reduced expression of NF-κB p65 and MLCK.
Taken together, these findings provide evidence that,
SJZD, is a potential protective agent ofintestinal bar-
rier function. Further investigation into the mechan-
ism of SJZD on intestinal barrier as well as in vivo
research is required.
Fig. 8 Effect of SJZDS on NF-κB signaling pathway. a SJZDS upregulated the activity of NF-κB transcription factor p65. b The figure
showed a representative western blot of NF-κB transcription factor p65 in TNBS-damaged Caco2 cells treated by SJZDS. c Quantification
of the amounts of p65relative to PCNA. d The figure showed a representative western blot of MLCK in TNBS-damaged Caco2 cells treated
by SJZDS. e Quantification of the amounts of MLCKrelative to GAPDH. Data represented the mean ± SEM of at least three independent experiments
(*P < 0.05, **P < 0.01 vs. control Caco2 cells group; #P < 0.05, ##P < 0.01 vs. TNBS-damaged Caco2 cells group)
Lu et al. BMC Complementary and Alternative Medicine  (2017) 17:35 Page 11 of 13
Abbreviations
CD: Crohn’s disease; H&E: Hematoxylin and eosin; IBD: Inflammatory bowel
disease; SASP: Salazosulfapyridine; SJZD: SijunziDecoction;
SJZDS: SijunziDecoction serum; TEER: Transepithelial electrical resistance;
TJ: Tight junction.; TNBS: 6-trinitrobenzene sulfonic acid; UC: Ulcerative colitis;
ZO1: Zonulaoccludens 1
Acknowledgments
We thank all of our colleagues in our team at the Guangdong Provincial
Hospital of Chinese Medicine for their excellent assistance of this study.
Funding
This work was supported by grants from the Natural Science Foundation of
China (Grant No.81202635)and Foundation of Guangdong Provincial Bureau
of Chinese Medicine (20151244).
Availability of data and materials
Data are all contained within the paper.
Authors’ contributions
Conception of idea and research design: LH. Conduct of research and
experimentation: YL, HJL, JWZ. Data analyses: YL, HJL. Drafting of manuscript:
YL. Review and approval of final manuscript: LH, JAW, JS. All authors read
and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
All the procedures were conducted in strict accordance with the PR
Chinalegislation on the use and care of laboratory animals, and with the
guidelines established by the Institute for Experimental Animals of Guangzhou
University of TCM, and were approved by the university ethical committee for
animalexperiments.
Received: 16 March 2016 Accepted: 19 December 2016
References
1. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med. 1991;325(13):
928–37.
2. Yamamoto-Furusho JK, Podolsky DK. Innate immunity in inflammatory
bowel disease. N Engl J Med. 1991;325(14):131–6.
3. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. World J
Gastroenterol. 1998;115(1):182–205.
4. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347(6):417–29.
5. Bouma G, Strober W. The immunological and genetic basis of inflammatory
bowel disease. Nat Rev Immunol. 2003;3(7):521–33.
6. Mitic LL, Van Itallie CM, Anderson JM. Molecular physiology and
pathophysiology of tight junctions I. Tight junction structure and function:
lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver
Physiol. 2000;279(2):G250–4.
7. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev
Immunol. 2009;9(11):799–809.
8. Pithadia AB, Jain S. Treatment of inflammatory bowel disease (IBD).
Pharmacol Rep. 2011;63(3):629–42.
9. Triantafyllidi A, Xanthos T, Papalois A, Triantafillidis JK. Herbal and plant
therapy in patients with inflammatory bowel disease. Ann Gastroenterol.
2015;28(2):210–20.
10. Wang X, Fan F, Cao Q. Modified Pulsatilla decoction attenuates oxazolone-
induced colitis in mice through suppression of inflammation and epithelial
barrier disruption. Mol Med Rep. 2016;14(2):1173–9.
11. Xu BL, Zhang GJ, Ji YB. Active components alignment of Gegenqinlian,
decoction protects ulcerative colitis by attenuating inflammatory and
oxidative stress. J Ethnopharmacol. 2015;13(162):253–60.
12. Fan H, Liu XX, Zhang LJ, Hu H, Tang Q, Duan XY, Zhong M, Shou ZX.
Intervention effects of QRZSLXF, a Chinese medicinal herb recipe, on the
DOR-β-arrestin1-Bcl2 signal transduction pathway in a rat model of
ulcerative colitis. J Ethnopharmacol. 2014;154(1):88–97.
13. Ji YF, Wang RJ, Li XB. Research progress on chemical constituents and
pharmacological effects of Sijunzi decoction. ChinTrad Herb Dr. 2016;47(5):
837–43.
14. An K, Jin-Rui G, Zhen Z, Xiao-Long W. Simultaneous Quantification of Ten
Active Components in Traditional Chinese Formula Sijunzi Decoction Using
a UPLC-PDA Method. J Anal Methods Chem. 2014;2014(11):570359.
15. Zhao SY, Wang CJ. Influence of Sijunzi decoction’s on T lymphocyte subsets
of gastric mucosa in rats with spleen-deficiency syndrome. Chin J Integr
Trad Med Dig. 2014;22(4):204–6.
16. Klingberg TD, Pedersen MH, Cencic A, Budde BB. Application of
measurements of transepithelial electrical resistance of intestinal epithelial
cell monolayers to evaluate probiotic activity. Appl Environ Microbiol. 2005;
71(11):7528–30.
17. Nishida M, Yoshida M, Nishiumi S, Furuse M, Azuma T. Claudin-2 regulates
colorectal inflammation via myosin light chain kinase-dependent signaling.
Dig Dis Sci. 2013;58(6):1546–59.
18. Sierro F, Dubois B, Coste A, Kaiserlian D, Kraehenbuhl JP, Sirard JC. Flagellin
stimulation of intestinal epithelial cells triggers CCL20-mediated migration
of dendritic cells. Proc Natl Acad Sci USA. 2001;98(24):13722–7.
19. Garrote JA, Gómez-González E, Bernardo D, Arranz E, Chirdo F. Celiac
disease pathogenesis: the proinflammatory cytokine network. J Pediatr
Gastroenterol Nutr. 2008;47 Suppl 1:S27–32.
20. Ivanov AI, Parkos CA, Asma N. Cytoskeletal regulation of epithelial barrier
function during inflammation. Am J Pathol. 2010;177(2):512–24.
21. Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function
and connections to the actin cytoskeleton. Biochimica EtBiophysica Acta
Biomembranes. 2008;1778(3):660–9.
22. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in
mice expressing a dominant negative N-cadherin. Science. 1995;270(5239):
1203–7.
23. Costantini TW, Peterson CY, Kroll L, Loomis WH, Eliceiri BP, Baird A, Bansal V.
Coimbra RRole of p38 MAPK in burn-induced intestinal barrier breakdown. J
Surg Res. 2009;156(156):64–9.
24. Yasuda T, Takeyama Y, Ueda T, Shinzeki M, Sawa H, Nakajima T, Kuroda Y.
Breakdown of intestinal mucosa via accelerated apoptosis increases
intestinal permeability in experimental severe acute pancreatitis. J Surg Res.
2006;135(135):18–26.
25. Seo GS, Jiang WY, Park PH, Sohn DH, Cheon JH, Lee SH. Hirsutenone
reduces deterioration of tight junction proteins through EGFR/Akt and
ERK1/2 pathway both converging to HO-1 induction. Biochem Pharmacol.
2014;90(2):115–25.
26. Yang L, Yang J, Cai Z. Chemical investigation on Sijunzi decoction and its
two major herbs Panax ginseng, and Glycyrrhizauralensis, by LC/MS/MS. J
Pharm Biomed Anal. 2006;41(5):1642–7.
27. Hao WW, Wen HZ, Ma GT, Tang ZP, He XY, Li J, Li NN, Liu YT. Ginsenoside-
Rg1regulates blood coagulation in DSS-induced colitis mice. Chin J Integr
Trad Med Dig. 2013;21(5):238–42.
28. Guo F, Li Z, Xu X, Wang K, Shao M, Zhao F, Wang H, Hua H, Pei Y, Bai J.
Butenolide derivatives from the plant endophytic fungus Aspergillusterreus.
Fitoterapia. 2016;113:44–50.
29. Zhang J, Lu Y, Wei J, Li L, Han L. Protective effect of
carboxytmethylpachymaran on TNF-α-induced damage in Caco-2 cell
monolayers. Int J BiolMacromol. 2016;93(Pt A):506–11.
30. Neurath M, Fuss I, Strober W. TNBS-colitis. Int Rev Immunol. 2000;19(19):51–62.
31. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel
disease.J PharmacolToxicol. Methods. 2004;50(2):81–92.
32. Brenna Ø, Furnes MW, Drozdov I, van BeelenGranlund A, Flatberg A, Sandvik
AK, Zwiggelaar RT, Mårvik R, Nordrum IS, Kidd M, Gustafsson BI. Relevance
of TNBS-colitis in rats: a methodological study with endoscopic, Histologic
and transcriptomic [corrected] characterization and correlation to IBD. PLoS
One. 2013;8(1):e54543.
33. Dou ZH, Luo L, Chen JY, AN LP, YANG AH. Analysis of lignans in serum
containing drug of Schisandrachinensis by UPLC-MS/MS. Chin J Clin
Pharmacol. 2013;29(3):215–8.
34. Wang X, Sun W, Sun H, Lv H, Wu Z, Wang P, Liu L, Cao H. Analysis of the
constituents in the rat plasma after oral administration of Yin Chen Hao
Tang by UPLC/Q-TOF-MS/MS. J Pharm Biomed Anal. 2008;46(3):477–90.
35. Wang P, Liang Y, Zhou N, Chen B, Yi L, Yu Y, Yi Z. Screening and analysis of
the multiple absorbed bioactive components and metabolites of
Lu et al. BMC Complementary and Alternative Medicine  (2017) 17:35 Page 12 of 13
dangguibuxue decoction by the metabolic fingerprinting technique and
liquid chromatography/diode-array detection mass spectrometry. Rapid
Commun Mass Spectrum. 2007;21(2):99.
36. Anselmi L, Huynh J, Duraffourd C, Jaramillo I, Vegezzi G, Saccani F, Boschetti
E, Brecha NC, De Giorgio R, Sternini C. Activation of μ opioid receptors
modulates inflammation in acute experimental colitis. Neurogastroenterol
Motil. 2015;27(4):509–23.
37. Funakoshi T, Yamashita K, Ichikawa N, Fukai M, Suzuki T, Goto R, Oura T,
Kobayashi N, Katsurada T, Ichihara S, Ozaki M, Umezawa K, Todo S. A novel
NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates
inflammatory colonic injury in mice. J Crohns Colitis. 2012;6(2):215–25.
38. Liu X, Xu J, Mei Q, Han L, Huang J. Myosin light chain kinase inhibitor
inhibits dextran sulfate sodium-induced colitis in mice. Dig Dis Sci. 2013;
58(1):107–14.
39. Blair SA, Kane SV, Clayburgh DR, Turner JR. Epithelial myosin light chain
kinase expression and activity are upregulated in inflammatory bowel
disease. Lab Invest. 2006;86(2):191–201.
40. Wadgaonkar R, Linz-McGillem L, Zaiman AL, Garcia JG. Endothelial cell
myosin light chain kinase (MLCK) regulates TNFalpha-induced NFkappaB
activity. J Cell Biochem. 2005;94(2):351–64.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Lu et al. BMC Complementary and Alternative Medicine  (2017) 17:35 Page 13 of 13
